Search Contract Opportunities

Tolterodine Tartrate ER 24HR Capsules   3

ID: SPE2D223R0001 • Type: Solicitation • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
Does this contract have any security clearance requirements?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: Feb. 8, 2023, 1:10 p.m. EST

Amendment 0004 issued February 08, 2023 to extend the solicitation closing date from February 09, 2023 3:00 PM EST to February 17, 2023 3:00 PM EST.

Amendment 0003 issued January 26, 2023 to extend the solicitation closing date from Janaury 26, 2023 3:00 PM EST to February 09, 2023 3:00 PM EST.

Amendment 0002 issued January 05, 2023 to extend the solicitation closing date from Janaury 12, 2023 3:00 PM EST to January 26, 2023 3:00 PM EST.

Amendment 0001 issued December 16, 2022 to incorporate statement, DoD Class Deviation 2023-O0001, Verification of Eligibility of Small Business Joint Ventures, into solicitation.

Solicitation SPE2D2-23-R-0001 Tolterodine Tartrate ER 24HR 4MG and Tolterodine Tartrate ER 24HR 2MG Capsules

Posted: Jan. 26, 2023, 1:35 p.m. EST
Posted: Jan. 5, 2023, 10:25 a.m. EST
Posted: Dec. 16, 2022, 9:52 a.m. EST
Posted: Dec. 7, 2022, 11:04 a.m. EST
Background
The Defense Logistics Agency (DLA) Troop Support, Directorate of Medical Materiel provides pharmaceutical products for the Department of Defense (DoD) to its customers through its Pharmaceutical Prime Vendor program. The Department of Veterans Affairs (VA) provides pharmaceutical products to its customers as well as the Indian Health Service (IHS) and the Bureau of Prisons (BoP) through the VA Pharmaceutical Prime Vendor Program. Hereafter these programs are collectively referred to as the “PPV.” A prime vendor is an independent business concern that functions as a purchaser's primary source for specified classes of products and is responsible for the delivery of goods produced by various suppliers. As a part of the Pharmaceutical Prime Vendor Program, this solicitation will establish a national contract for the items listed in the schedule. The PPV Programs consist of separate contracts which establish the fees for the distribution of pharmaceutical products that are distributed through the PPV Programs on Federal Government (i.e., Federal Supply Schedules, DLA National Contracts) contracts. The awardee consents to allow VA and DLA Troop Support Prime Vendors to distribute the listed products in the schedule.

Work Details
Tolterodine Tartrate ER 24HR Capsules
SOW:
Table of Contents
Continuation of Blocks from the Standard Form 1449
Block 9, Issued By
Block 17a, Contractor/Offeror
Block 17b, Remittance Address
Block 19-22, Item No., Schedule of Supplies/Services, Quantity, Unit
Contractor Code of Business Ethics
Caution Notices
Contract Clauses
Contract —Commercial Items (by reference, see SF 1449, Block 27a) (NOV 2021)
Contract Required to Implement Statutes or Executive Orders—Commercial Items (OCT 2022)
Commercial and Government Entity Code Maintenance (AUG 2020)
Clauses Incorporated by Reference (FEB 1998)
Authorized Deviations in Clauses (NOV 2020)
Requirements (OCT 1995)
Evaluation of Options (JUL 1990)
Option to Extend the Term of the Contract (MAR 2000)
F.o.B Destination (JAN 1991)
Statement of Work

Period of Performance
The Contract Price Effective Date shall be no more than 60 calendar days after award, but no sooner than March 09, 2023. The contract performance date shall be 45 calendar days (or sooner upon mutual agreement) after the date of contract award.

Overview

Response Deadline
Feb. 17, 2023, 3:00 p.m. EST (original: Jan. 12, 2023, 3:00 p.m. EST) Past Due
Posted
Dec. 7, 2022, 11:04 a.m. EST (updated: Feb. 8, 2023, 1:10 p.m. EST)
Set Aside
None
Place of Performance
Not Provided
Source

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 12/7/22 DLA Troop Support - Medical issued Solicitation SPE2D223R0001 for Tolterodine Tartrate ER 24HR Capsules due 2/17/23. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Phyllis Daraio   Profile
Phone
(215) 737-7941

Documents

Posted documents for Solicitation SPE2D223R0001

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D223R0001

Award Notifications

Agency published notification of awards for Solicitation SPE2D223R0001

IDV Awards

Indefinite delivery vehicles awarded through Solicitation SPE2D223R0001

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D223R0001

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D223R0001

Experts for Tolterodine Tartrate ER 24HR Capsules

Recommended experts avaliable for hire

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
Feb. 8, 2023
Last Updated By
phyllis.daraio@dla.mil
Archive Date
Sept. 30, 2029